Form D Worth Mentioning: Nob Hill Therapeutics $250000 Financing. Jee Shin Filed Nov 15 D Form

Nob Hill Therapeutics, Inc. - Jee Shin

Nob Hill Therapeutics Financing

Nob Hill Therapeutics, Inc., Corporation just had published form D because of $250,000 equity financing. This is a new filing. Nob Hill Therapeutics was able to fundraise $112,500 so far. That is 45.00% of the offering. The total fundraising amount was $250,000. The fundraising form was filed on 2016-11-15. The reason for the financing was: unspecified. The fundraising still has about $137,500 more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Nob Hill Therapeutics is based in Arkansas. The firm’s business is not disclosed. The form was signed by Jee Shin Chief Executive Officer. The company was incorporated in 2016. The filler’s address is: 3525 Del Mar Heights Road #610, San Diego, Ca, California, 92130. Jee Shin is the related person in the form and it has address: 535 W. Research Center Blvd., Suite 135, Fayetteville, Ar, Arkansas, 72701. Link to Nob Hill Therapeutics Filing: 000169004116000001.

Analysis of Nob Hill Therapeutics Offering

On average, startups in the not disclosed sector, sell 67.77% of the total offering size. Nob Hill Therapeutics sold 45.00% of the offering. The fundraising is still open. The average offering amount for companies in all industries in our database is $3.05 million. The offering was 96.31% smaller than the average of $3.05 million. Of course this should not be seen as negative. Startups get financed for different needs and reasons. The minimum investment for this financing was set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Nob Hill Therapeutics Also

The Form D signed by Jee Shin might help Nob Hill Therapeutics, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment